210 related articles for article (PubMed ID: 19455605)
1. Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
Johansson M; McKay JD; Rinaldi S; Wiklund F; Adami HO; Grönberg H; Kaaks R; Stattin P
Prostate; 2009 Sep; 69(12):1281-91. PubMed ID: 19455605
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the SST gene and its receptors in relation to circulating levels of insulin-like growth factor-I, IGFBP3, and prostate cancer risk.
Johansson M; McKay JD; Wiklund F; Rinaldi S; Hallmans G; Bälter K; Adami HO; Grönberg H; Stattin P; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1644-50. PubMed ID: 19423539
[TBL] [Abstract][Full Text] [Related]
3. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
[TBL] [Abstract][Full Text] [Related]
5. IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
Rosendahl AH; Hietala M; Henningson M; Olsson H; Jernström H
Breast Cancer Res Treat; 2011 Jun; 127(3):785-94. PubMed ID: 21140206
[TBL] [Abstract][Full Text] [Related]
6. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
[TBL] [Abstract][Full Text] [Related]
8. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
Park K; Kim JH; Jeon HG; Byun SS; Lee E
Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
[TBL] [Abstract][Full Text] [Related]
10. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.
Wong HL; Delellis K; Probst-Hensch N; Koh WP; Van Den Berg D; Lee HP; Yu MC; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):144-51. PubMed ID: 15668488
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C; Brisson J; Bérubé S; Pollak M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
[TBL] [Abstract][Full Text] [Related]
13. Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction.
Murisier-Petetin G; Gremlich S; Damnon F; Reymondin D; Hohlfeld P; Gerber S
Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):15-20. PubMed ID: 19217707
[TBL] [Abstract][Full Text] [Related]
14. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
[TBL] [Abstract][Full Text] [Related]
15. Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.
Lindström S; Wiklund F; Adami HO; Bälter KA; Adolfsson J; Grönberg H
Cancer Res; 2006 Nov; 66(22):11077-83. PubMed ID: 17108148
[TBL] [Abstract][Full Text] [Related]
16. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
[TBL] [Abstract][Full Text] [Related]
17. Influence of MUC1 genetic variation on prostate cancer risk and survival.
Strawbridge RJ; Nister M; Brismar K; Li C; Lindström S
Eur J Hum Genet; 2008 Dec; 16(12):1521-5. PubMed ID: 18628787
[TBL] [Abstract][Full Text] [Related]
18. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival.
Hayes VM; Severi G; Southey MC; Padilla EJ; English DR; Hopper JL; Giles GG; Sutherland RL
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1223-5. PubMed ID: 16775185
[TBL] [Abstract][Full Text] [Related]
19. Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk.
Feik E; Baierl A; Hieger B; Führlinger G; Pentz A; Stättner S; Weiss W; Pulgram T; Leeb G; Mach K; Micksche M; Gsur A
Cancer Causes Control; 2010 Jan; 21(1):91-7. PubMed ID: 19784788
[TBL] [Abstract][Full Text] [Related]
20. Haplotype-based analysis of common variation in the growth hormone receptor gene and prostate cancer risk.
McKay JD; Kaaks R; Johansson M; Biessy C; Wiklund F; Bälter K; Adami HO; Boillot C; Gioia-Patricola L; Canzian F; Stattin P; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):169-73. PubMed ID: 17220348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
